ANGPT1 and acute myeloid leukemia: We previously demonstrated that higher expression of Ang-2, but not Ang-1, in the BM was a poor prognostic factor for overall survival in AML, particularly in the subgroup with high VEGF-A or VEGF-C levels (Hou et al, 2008).